BackAtea Pharmaceuticals Overview

Atea Pharmaceuticals Total Assets

Latest total assets for AVIR: $200M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$200.71M
↓ 41.48% YoYΔ $-142.26M vs prior year quarter

Peer trimmed avg / median

Loading

Atea Pharmaceuticals Total Assets History

Loading

Atea Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Atea Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Atea Pharmaceuticals (AVIR) FAQ

As of the most recent data (September 2026), AVIR shows a total assets of $200M. That compares with $340M in the prior-year period — down 41.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVIR's total assets is now $200M (was $340M) — a 41.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Atea Pharmaceuticals is outperforming or lagging.

Tracking AVIR's total assets over time shows whether Atea Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $340M in the prior-year period — down 41.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Atea Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $200M) with ownership activity and broader fundamentals.

Atea Pharmaceuticals's total assets is $200M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.